Summary
Sherry Danese is a healthcare commercial executive with 30+ years of cross-sector experience—spanning pharmaceuticals, biotech, devices, diagnostics and health IT—focused on launch strategy, accelerated growth and innovation. She has led brand and pipeline commercialization at Amgen and offered strategic, evidence-based consulting to clients including Amgen, Genentech, Veracyte and Shire through Outcomes Insights and Silver Ridge Advisors. Her strengths include opportunity assessment, launch planning, competitive intelligence and franchise optimization, with therapeutic breadth across neurology, oncology, gastroenterology, respiratory and rare diseases. Notably, she combines regulatory insight from a prior FDA review role with hands-on commercial P&L leadership and market research capabilities, enabling pragmatic go-to-market plans tied to financial forecasts. Sherry often drives innovation at the intersection of diagnostics and clinical trials, recently advising on an online cognitive test and commercial models for ILD and endometriosis diagnostics. She holds an MBA and a BS in Chemistry from the University of Virginia and is based in California.
11 years of coding experience
10 years of employment as a software developer
MBA, MBA at University of Virginia, The Darden Graduate School of Business Administration
B.S., Chemistry, B.S., Chemistry at University of Virginia
Wootton
MBA, Business, MBA, Business at University of Virginia Darden School of Business